TrialRespiratory research2024

Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomized controlled trial.

Naglaa Hamdi Eltahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.